Does TALAZOPARIB Cause Platelet count decreased? 68 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Platelet count decreased have been filed in association with TALAZOPARIB (Talzenna). This represents 4.6% of all adverse event reports for TALAZOPARIB.
68
Reports of Platelet count decreased with TALAZOPARIB
4.6%
of all TALAZOPARIB reports
8
Deaths
30
Hospitalizations
How Dangerous Is Platelet count decreased From TALAZOPARIB?
Of the 68 reports, 8 (11.8%) resulted in death, 30 (44.1%) required hospitalization, and 25 (36.8%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
Yes, Platelet count decreased is listed as a known adverse reaction in the official FDA drug label for TALAZOPARIB.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Haemoglobin decreased (65)
Febrile neutropenia (60)
Pancytopenia (60)
Nausea (53)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which TALAZOPARIB Alternatives Have Lower Platelet count decreased Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS